EHA Highlights

flipper_slider

Editor's Choice

Mareike Aichholzer discusses her poster presentation on the comprehensive monitoring of gut microbiota during therapy for acute leukaemia. FILMED AT THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA) ANNUAL MEETING, JUNE...

EHA Highlights Videos

Maria Cappellini discusses Gaucher disease and the consequences of late diagnosis. FILMED AT THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA) ANNUAL MEETING, JUNE 2016 CAN YOU TELL US SOMETHING ABOUT GAUCHER DISEASE AND THE CONSEQUENCES OF NOT DIAGNOSING IT EARLY? 00:10 – Gaucher disease is a...
Christian Buske discusses Waldenström’s macroglobulinemia and the aims and findings of the pan-European data platform. FILMED AT THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA) ANNUAL MEETING, JUNE 2016 WHAT IS WALDENSTRÖM’S MACROGLOBULINEMIA (WM)? 00:10 – Waldenström’s Macroglobulinemia belongs...
Ruben Mesa talks about the clinical assessments involved in identifying inadequately controlled polycythemia vera (PV), and discusses strategies to help to improve the quality of life of patients with PV. Disclosures: Ruben Mesa is a consultant to Novartis, Ariad and Galena, and has received...
Michele Baccarani discusses the factors influencing the decision to switch tyrosine kinase inhibitor (TKI) therapy in chronic myeloid leukaemia and the options available for patients who develop the T315I "gatekeeper" mutation. Disclosures: Michele Baccarani has received honoraria from ARIAD,...
Mareike Aichholzer discusses her poster presentation on the comprehensive monitoring of gut microbiota during therapy for acute leukaemia. FILMED AT THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA) ANNUAL MEETING, JUNE 2016 WHAT IS THE IMPACT ON THE GUT MICROBIOTA ON TREATMENT RESPONSE IN ACUTE...
Andrew Spencer discusses the role ofhistone deacetylase (HDAC) inhibition in multiple myeloma and what we need to understand better to explore the further potential of HDAC inhibition. FILMED AT THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA) ANNUAL MEETING, JUNE 2016 WHY IS HISTONE DEACETYLASE (...
Nicolaus Kroeger discusses the phase III study for the prevention of chronic graft-versus-host disease published earlier this year, and the ongoing research to further explore the role of anti T-lymphocyte globulin. FILMED AT THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA) ANNUAL MEETING, JUNE 2016...
Christian Gisselbrecht explains the key findings of the SCHOLAR-1 study and the ongoing research to address the unmet need in the treatment of refractory aggressive diffuse large B-cell lymphoma (DLBC) FILMED AT THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA) ANNUAL MEETING, JUNE 2016 WHAT ARE THE...
Neils Weinhold talks about the diagnostic challenges posed by tumour heterogeneity in multiple myeloma and the impact of this heterogeneity on targeted treatment. FILMED AT THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA) ANNUAL MEETING, JUNE 2016 WHAT IS THE LEVEL OF SPATIAL HETEROGENEITY IN...
Maria-Victoria Mateos discusses the rationale and key findings of the Tourmaline-MM1 study, along with the ongoing studies investigating IRD (ixazomib-lenalidomide-dexamethasone) in multiple myeloma. Disclosures: Maria-Victoria Mateos has received honoraria from Janssen, Celgene, Takeda, Amgen...
Maria Cappellini discusses the Sherlock Holmes Symposia as it reaches its 10 year anniversary and the challenges of diagnosing rare haematological conditions. View part 2 of Dr Cappellini's interview HERE